Related Experiment Video

Updated: Jun 8, 2026

Knee Arthrocentesis in Adults
04:41

Knee Arthrocentesis in Adults

Published on: February 25, 2022

A reappraisal of intra-articular corticosteroid therapy in juvenile idiopathic arthritis

C Scott1, S Meiorin, G Filocamo

  • 1Istituto di Ricovero e Cura a Carattere Scientifico G. Gaslini, Genova, Italy, and 2School of Adolescent and Child Health, University of Cape Town, South Africa. christiaanscott@gmail.com

Clinical and Experimental Rheumatology
|September 25, 2010
PubMed

Insights

Intraarticular corticosteroid (IAC) injections offer safe and effective synovitis treatment for children with juvenile idiopathic arthritis (JIA). Further research is needed to confirm long-term disease-modifying effects and optimal use in JIA management.

Area of Science:

  • Pediatric Rheumatology
  • Musculoskeletal Disorders
  • Pharmacology

Background:

  • Juvenile idiopathic arthritis (JIA) is a common rheumatic disease in children, characterized by joint inflammation (synovitis).
  • Intraarticular corticosteroid (IAC) injections are a recognized treatment modality for localized synovitis in JIA.
  • Current evidence on the long-term efficacy and disease-modifying potential of IAC therapy in JIA is limited.

Purpose of the Study:

  • To review the current evidence on the use of intraarticular corticosteroid (IAC) injections in managing juvenile idiopathic arthritis (JIA).
  • To discuss the safety, efficacy, and optimal application of IAC therapy in pediatric patients with JIA.
  • To highlight areas requiring further investigation regarding the role of IACs in JIA management.

Main Methods:

  • Literature review of studies on intraarticular corticosteroid injections for juvenile idiopathic arthritis.
  • Analysis of available data on safety, efficacy, and specific corticosteroid preparations.
  • Discussion of procedural aspects, including anesthesia and imaging guidance (e.g., ultrasound).

Main Results:

  • IAC injections are safe and provide rapid symptom relief for synovitis in JIA, suitable for ambulatory settings.
  • Triamcinolone hexacetonide is often preferred, with more soluble agents recommended for smaller joints.
  • Ultrasound guidance is increasingly used for accurate needle placement.
  • IACs are commonly used for oligoarthritis, with potential application in polyarticular JIA alongside other therapies.

Conclusions:

  • Intraarticular corticosteroid (IAC) injections are a valuable tool for managing synovitis in children with juvenile idiopathic arthritis (JIA).
  • Optimal corticosteroid choice and procedural techniques, including imaging guidance, enhance treatment effectiveness.
  • Further controlled studies are essential to ascertain the long-term disease-modifying effects and establish the definitive role of IAC therapy in the comprehensive management of JIA.

Related Concept Videos

Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids01:21

Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids

Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2 (COX-2),...
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents01:29

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel Disease...
Inflammatory Bowel Disease IV: Pharmacological Management01:29

Inflammatory Bowel Disease IV: Pharmacological Management

Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids01:25

Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids

Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF01:24

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab (Humira),...
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...